AHA 2022: Bivalirudin With a Post-PCI High-Dose Infusion versus Heparin Monotherapy During Primary PCI in STEMI - The Randomized BRIGHT-4 Trial

November 14, 2022

0 Comments
Login to view comments. Click here to Login